Healthcare Global Enterprises Completes Dispatch of Rights Issue Documents
Healthcare Global Enterprises Limited completed dispatch of its rights issue Letter of Offer on March 4, 2026, and published mandatory newspaper advertisements on March 6, 2026. The rights issue offers up to 8,294,566 equity shares at ₹512.00 per share, aggregating up to ₹42,468.18 lakhs, in a 1:17 subscription ratio. The issue opens March 11, 2026, and closes March 25, 2026, with mandatory ASBA application process for eligible shareholders.

*this image is generated using AI for illustrative purposes only.
Healthcare Global Enterprises Limited has completed the dispatch of its Letter of Offer for a significant rights issue, marking a key milestone in the company's capital raising initiative. The oncology-focused healthcare provider published mandatory newspaper advertisements on March 6, 2026, confirming compliance with SEBI regulations for its upcoming rights offering.
Rights Issue Overview
The company's rights issue presents substantial details for eligible shareholders:
| Parameter: | Details |
|---|---|
| Issue Size: | Up to 8,294,566 equity shares |
| Face Value: | ₹10.00 per share |
| Issue Price: | ₹512.00 per share |
| Premium: | ₹502.00 per share |
| Total Value: | Up to ₹42,468.18 lakhs |
| Subscription Ratio: | 1:17 |
| Record Date: | March 2, 2026 |
Key Timeline and Dates
The rights issue follows a structured timeline with specific dates for various activities:
| Event: | Date |
|---|---|
| Issue Opens: | March 11, 2026 |
| Last Date for On-Market Renunciation: | March 20, 2026 |
| Issue Closes: | March 25, 2026 |
| Dispatch Completion: | March 4, 2026 |
Regulatory Compliance and Publication
Healthcare Global Enterprises fulfilled its regulatory obligations by publishing advertisements in three newspapers with wide circulation on March 6, 2026. The publications included Financial Express (English national daily), Jansatta (Hindi national daily), and Vishwavanani (Kannada daily newspaper for the regional language of Bengaluru). This publication complies with sub-regulation (1) of Regulation 84 of the SEBI ICDR Regulations.
Application Process and Requirements
The rights issue mandates the use of ASBA (Applications Supported by Blocked Amount) process for all applications. Eligible equity shareholders holding shares in physical form must provide demat account details at least two working days before the issue closing date. The company has arranged with NSDL and CDSL for crediting rights entitlements under ISIN: INE075I01017.
Document Availability and Access
The Letter of Offer dated February 24, 2026, along with application forms and rights entitlement letters, has been dispatched to eligible shareholders. Electronic copies were sent to shareholders who provided valid email addresses, while physical copies were dispatched to Indian addresses on a reasonable effort basis. The documents are accessible on the company's website, registrar's portal, and stock exchange websites.
Trading and Listing Information
Existing equity shares trade on BSE (Scrip Code: 539787) and NSE (Symbol: HCG). Rights entitlements will be tradable in dematerialized form with a market lot of one rights entitlement during the renunciation period from March 11 to March 20, 2026.

































